Transarterial Radioembolization of Hepatocellular Carcinoma, Liver-Dominant Hepatic Colorectal Cancer Metastases, and Cholangiocarcinoma Using Yttrium90 Microspheres: Eight-Year Single-Center Real-Life Experience
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Transarterial Radioembolization of Hepatocellular Carcinoma, Liver-Dominant Hepatic Colorectal Cancer Metastases, and Cholangiocarcinoma Using Yttrium90 Microspheres: Eight-Year Single-Center Real-Life Experience |
| Type de publication | Journal Article |
| Year of Publication | 2021 |
| Auteurs | Pellegrinelli J, Chevallier O, Manfredi S, Dygai-Cochet I, Tabouret-Viaud C, Nodari G, Ghiringhelli F, Riedinger J-M, Popoff R, Vrigneaud J-M, Cochet A, Aho S, Latournerie M, Loffroy R |
| Journal | DIAGNOSTICS |
| Volume | 11 |
| Pagination | 122 |
| Date Published | JAN |
| Type of Article | Article |
| Mots-clés | Adverse events, cholangiocarcinoma, Colorectal cancer, hepatocellular carcinoma, liver metastases, Radioembolization, selective internal radiation therapy, survival, yttrium-90 |
| Résumé | {Liver tumors are common and may be unamenable to surgery or ablative treatments. Consequently, other treatments have been devised. To assess the safety and efficacy of transarterial radioembolization (TARE) with Yttrium-90 for hepatocellular carcinoma (HCC), liver-dominant hepatic colorectal cancer metastases (mCRC), and cholangiocarcinoma (CCA), performed according to current recommendations, we conducted a single-center retrospective study in 70 patients treated with TARE (HCC |
| DOI | 10.3390/diagnostics11010122 |